THORNBERRY NANCY sold 36.8% of their position (11.44K shares) of DENALI THERAPEUTICS INC. on the open market
Open‑market sale worth $261.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/4/2026ACC: 0001797826-26-000006
-11.44K
Net shares
Net seller
$261.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
11.44K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−10.82K
Price / share
$22.85
Trade value
$247.33K
% of position
34.8%
9/2/2026
31.13K→20.30K
Common Stock
Direct
Shares
−615.00
Price / share
$23.74
Trade value
$14.60K
% of position
3.0%
9/2/2026
20.30K→19.69K
Total
Net shares
−11.44K
Net value
-$261.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | S · Sale | −10.82K | $22.85 | $247.33K | 34.8% | 31.13K | 20.30K |
| Common Stock Direct | 9/2/2026 | S · Sale | −615.00 | $23.74 | $14.60K | 3.0% | 20.30K | 19.69K |
| Total | −11.44K | -$261.93K | ||||||
Derivative Transactions0
No derivative transactions reported